Expression patterns of miR-221 and its target Caspase-3 in different cancer cell lines

Suppression of Dicer Increases Sensitivity to Gefitinib in Human Lung Cancer Cells

(2014) Jui-Chieh Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer

(2014) M Wang et al.   BRITISH JOURNAL OF CANCER

miR-221/222 control luminal breast cancer tumor progression by regulating different targets

(2014) Patrizia Dentelli et al.   CELL CYCLE

Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies

(2014) Juliana I. Santos et al.   TUMOR BIOLOGY

miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells

(2013) Rounak Nassirpour et al.   PLoS One

miR-221/222: promising biomarkers for breast cancer

(2013) Wei-Xian Chen et al.   TUMOR BIOLOGY

Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors

(2011) Gonzalo Rodríguez-Berriguete et al.   HUMAN PATHOLOGY

MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2

(2011) Chang Zheng et al.   MEDICAL ONCOLOGY

The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

(2011) Tong Sun et al.   PROSTATE

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

(2011) Maitri Y Shah et al.   Genome Medicine

MicroRNAs and prostate cancer

(2010) Y. Pang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity

(2010) Lei Shi et al.   BRAIN RESEARCH

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

(2010) Chun-Zhi Zhang et al.   Molecular Cancer

SnapShot: MicroRNAs in Cancer

(2009) Riccardo Spizzo et al.   CELL

Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets

(2009) Simone Treiger Sredni et al.   CHILDS NERVOUS SYSTEM

MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality

(2009) L. Gramantieri et al.   CLINICAL CANCER RESEARCH

Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells

(2009) Kazuya Terasawa et al.   FEBS Journal

MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL

(2009) Qiang Lu et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Caspase activation cascades in apoptosis

(2008) Susan E. Logue et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Caspase-8 in cancer biology and therapy

(2008) Simone Fulda   CANCER LETTERS

The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms

(2008) F. Felicetti et al.   CANCER RESEARCH

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

(2008) S. Ambs et al.   CANCER RESEARCH

Caspases in apoptosis and beyond

(2008) J Li et al.   ONCOGENE